Welcome to our dedicated page for 1606 news (Ticker: CBDW), a resource for investors and traders seeking the latest updates and insights on 1606 stock.
1606 Corp. (CBDW) delivers AI-powered chatbot solutions transforming digital customer interactions and investor relations. This dedicated news hub provides comprehensive access to corporate announcements, strategic developments, and operational updates.
Track all official communications including product launches, technology partnerships, and regulatory filings. Investors gain timely insights into the company’s innovations in natural language processing and machine learning applications across industries.
Discover updates on CBDW’s enterprise solutions for investor research automation, customer engagement platforms, and cross-sector AI implementations. Our curated news collection serves analysts and stakeholders seeking to monitor progress in AI-driven digital transformation.
Bookmark this page for streamlined access to verified information about 1606 Corp.’s market position, technological advancements, and compliance with evolving industry standards.
1606 Corp. (OTC Pink:CBDW) has reported key developments in Q4, including the filing of its Annual Report on Form 10-K for 2024 and plans to attend the IPO Summit 2025 on April 15 in New York. The company is actively engaged in discussions regarding potential mergers and up-listing opportunities to major exchanges.
The company has made progress in enhancing its AI-powered chatbot solutions through advanced machine learning models and natural language processing techniques, targeting sectors like e-commerce, finance, healthcare, and telecommunications. Strategic partnerships have been advanced across waste management, distribution, and biotech industries.
For 2025, 1606 Corp's priorities include enhancing AI solutions with new features, expanding market presence in high-growth verticals, and driving revenue growth through increased adoption of AI-powered solutions like Chat IR.
1606 Corp. (OTC Pink:CBDW) has signed a non-binding Letter of Intent (LOI) with a private group led by Jon Garfield and Chuck Arnold for the acquisition of a controlling position in the company for $1 million. The group plans to enter public markets and utilize AI technologies for potential uplisting.
The acquiring group aims to leverage 1606's AI platform to consolidate and innovate in the waste management sector. The transaction, subject to due diligence, regulatory approvals, and definitive agreements, is expected to close in the coming months. Key management is anticipated to remain post-acquisition.
1606's AI platform, which has been successful across CBD, public companies, and other verticals, will be expanded into waste management applications, including waste stream separation and nationwide fleet management. The deal represents a strategic move to combine 1606's AI capabilities with waste management operations.
1606 Corp (OTC PINK:CBDW) welcomes RedChip Companies' launch of RedChat, viewing it as validation of their own AI-powered IR chatbot launched in early 2024. The company's chatbot, built using Microsoft's Azure, Copilot, and Chat GPT integration, provides real-time access to financial filings, press releases, and corporate disclosures for thousands of publicly traded companies.
RedChat offers insights into over 2,000 small-cap and microcap stocks, similar to 1606 Corp's existing solution. The company's proprietary AI technology aims to simplify investment research by allowing users to quickly access specific company information through natural language queries. The technology is fully owned by 1606 Corp and is available for other companies and IR firms seeking to enhance their investor relations capabilities.
GPO Plus (OTCQB:GPOX) has announced a strategic partnership with 1606 Corp (OTC PINK:CBDW) to enhance its PRISM+ platform with advanced AI capabilities. The collaboration aims to revolutionize distribution services for gas stations and convenience stores, a market generating over $327.6 Billion in annual in-store sales across 152,396 locations.
The partnership focuses on integrating AI solutions into GPOX's proprietary PRISM+ platform to optimize logistics, inventory management, and operational efficiencies. Key enhancements include AI-driven route optimization, predictive inventory management, retail insights, demand forecasting, and continuous performance monitoring.
GPOX's strategy targets the 15-20% of high-margin convenience store products not handled by major distributors. The partnership is already active, with AI development and integration underway to transform traditional distribution networks that currently operate on 10-30+ year-old technology stacks.
1606 Corp. (OTC PINK:CBDW) has announced a strategic partnership with GPO Plus, Inc. (OTCQB:GPOX) to enhance AI-driven distribution solutions. The partnership focuses on improving GPOX's PRISM+ platform through advanced AI services, targeting the gas station and convenience store industries.
Under the agreement, 1606 Corp will provide five key services: AI Development & Optimization, Data Integration & Analytics, Edge Computing, Training & Support, and Performance Monitoring & Optimization. The collaboration aims to optimize inventory management, streamline deliveries, and enhance operational excellence through real-time data-driven decisions.
The partnership is effective immediately, with development and implementation already underway. The integration focuses on leveraging diverse data sources, including IoT sensors, weather data, and satellite imagery, to drive actionable insights and improve customer satisfaction.
1606 Corp. (OTC Pink:CBDW), a leader in AI solutions, announces plans to leverage industry-wide cost reductions in data management and analytics to offer more affordable services. The company has successfully launched two specialized chatbot solutions in the past year: one for the CBD industry and another for public companies, priced at $99 per month.
The cost reductions enable 1606 Corp. to make sophisticated AI-driven technologies more accessible to smaller businesses, particularly in emerging industries like CBD. The company's solutions aim to improve customer engagement, streamline communications, and enhance operational efficiencies. The decreased costs in data management tools have helped reduce operational expenses, allowing the company to maintain competitive pricing while delivering high-quality solutions.
1606 Corp. (OTC Pink:CBDW) has expressed support for Adnexus Biotechnologies following their announcement of Trapicolast, a groundbreaking antimalarial drug developed using their AI-powered Sutra™ platform. The drug targets dual mechanisms within the Plasmodium parasite, specifically focusing on the apicoplast's DNA synthesis and vesicular trafficking pathways.
Trapicolast was developed by analyzing over 8 million molecular compounds through AI, resulting in the identification of ADX1 and ADX2 compounds. The drug's dual-target mechanism makes it particularly effective against drug-resistant malaria strains in regions like Sub-Saharan Africa and Southeast Asia.
While a previous Letter of Intent for strategic investment between 1606 Corp. and Adnexus terminated on November 28, 2024, both companies are continuing efforts to close the transaction. The development validates the potential of the Sutra™ AI platform in drug discovery, with Adnexus planning to advance the malaria drug in collaboration with partners in India.
1606 Corp. (OTC Pink:CBDW) has expressed strong support for Adnexus Biotechnologies' new Neural Temporal Fingerprinting technology, which combines AI-driven analysis of EEG and ECG signals for health monitoring. The technology focuses on neurological prediction for conditions like Alzheimer's and PTSD, and cardiovascular risk assessment for heart-related conditions.
While a previous Letter of Intent for strategic investment between the companies terminated on November 28, 2024, both parties are continuing efforts to close the transaction. The partnership aims to advance AI-powered healthcare solutions and position both companies for growth in the personalized medicine market.
1606 Corp. (OTC PINK:CBDW) reports progress in Q3 2024, focusing on AI chatbot market expansion and strategic partnerships. The company has filed its 10-Q for Q3 2024, maintaining current SEC filing status. Key developments include signing a Letter of Intent with Adnexus Biotechnologies for potential strategic investment in AI and biotechnology solutions. The company has created two chatbots (available at cbdw.ai) and plans to expand into e-commerce, finance, healthcare, and telecommunications sectors. Future focus includes closing the Adnexus investment, launching additional AI chatbot solutions, and expanding market presence.
1606 Corp (OTC PINK:CBDW) announces that its investment target Adnexus Biotechnologies has completed a merger agreement to acquire Sanctum Therapeutics' core technology assets for HIV and SARS-CoV-2 treatments. The merger combines Adnexus's AI-driven drug discovery platform with Sanctum's long-acting HIV capsid inhibitor and Adnexus's anti-HIV monoclonal antibodies. 1606 Corp has executed a Letter of Intent for a 5% strategic investment in Adnexus, with the LOI terminating on November 27, 2024.
